ea0035p1109 | Thyroid Cancer | ECE2014
Katalinic Darko
, Santek Fedor
, Juretic Antonio
, Stern-Padovan Ranka
, Nikolac Nora
, Grah Josip Joachim
, Plestina Stjepko
In the recent years, knowledge about cancer biomarkers has increased tremendously providing great opportunities for improving the diagnosis, prognosis and treatment of cancer patients. In clinical practice, the levels of serum calcitonin, and carcinoembryonic antigen (CEA) are important during follow-up for patients with medullary thyroid cancer (MTC). Carbohydrate antigen 19-9 (CA 19-9), routinely used in the monitoring of pancreatic, hepatobiliary, and colon carcinoma, also ...